# Evaluation of the Effectiveness of Platelet-based and Microvesicle-based Assays to Predict Thrombotic and Bleeding Risk in Chronic Kidney Disease Patients With Acute Coronary Syndrome

> **NCT06026436** · NA · RECRUITING · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 850 (estimated)

## Conditions studied

- Chronic Kidney Disease stage3

## Interventions

- **BIOLOGICAL:** Blood samples
- **BIOLOGICAL:** Blood samples

## Key facts

- **NCT ID:** NCT06026436
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-12
- **Primary completion:** 2026-10
- **Final completion:** 2026-12
- **Target enrollment:** 850 (ESTIMATED)
- **Last updated:** 2023-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06026436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06026436, "Evaluation of the Effectiveness of Platelet-based and Microvesicle-based Assays to Predict Thrombotic and Bleeding Risk in Chronic Kidney Disease Patients With Acute Coronary Syndrome". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06026436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*